GlassScriptPhysician profile
Pejmon Patrick Estakhri
NPI 1215460506
$1,766.44
in general payments reported to CMS, 2019-2025
7 companies · $15.95 in 2025
The $15.95 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $23.30 · 2022: $125 · 2023: $1,231 · 2024: $372 · 2025: $15.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,086 · Food and Beverage: $532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,086.08 |
| Food and Beverage | $532.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,137.39 | 2023 | Davinci Xi, Da Vinci Surgical System |
| Medtronic, INC. | $132.40 | 2024 | Signia |
| Boston Scientific Corporation | $126.92 | 2024-2025 | Axonics |
| Ethicon US, LLC | $124.92 | 2022 | |
| Baxter Healthcare | $113.42 | 2024 | Perclot |
| Tela Bio, INC. | $108.09 | 2023-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Integra Lifesciences Corporation | $23.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pejmon Estakhri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.